Tom Abrams’ Steady Leadership Guided US FDA Through Dramatic Changes In Rx Promotion

 
• By Brenda Sandburg
  
Time - Abstract illustration
FDA's Tom Abrams retires from FDA after 27 years regulating Rx drug promotions

More from Marketing & Advertising

More from Compliance